Corporate Profile

Overview

Founded April 16, 1913
Incorporated April 28, 1945
Paid-In Capital ¥7.2 billion; listed on the First Section of the Tokyo Stock Exchange
Employees 1,617 (Consolidated) ※As of March 2019
Head Office 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 160-8515, Japan
Tel +81-3-3358-7211
Fax +81-3-3358-7887

Members of the Board

As of June 27, 2019
President Naoyuki Mochida
Senior Executive Managing Directors Chu Sakata
Keiichi Sagisaka
Executive Managing Directors Yoichi Kono
Junichi Sakaki,Ph.D.
Kiyoshi Mizuguchi, Ph.D.
Executive Directors Yutaka Kawakami, Ph.D.
Yoshiharu Hashimoto
Outside Directors Tomoo Kugisawa
Hirokuni Sogawa

Audit & Supervisory Board Members

As of June 27, 2019
Full-time Audit & Supervisory Board Members Ichiro Takahashi
Kazuhiro Miyaji
Outside Audit & Supervisory Board Members Hiroshi Watanabe
Kyosuke Wagai
Akiko Suzuki

Executive Officers

As of June 27, 2019
Executive Officers Takayuki Kato
Kazumasa Fukuchi
Shigeharu Suzuki
Hitoshi Mizuno
Taiji Hayano
Tomokazu Matsusue
Tadashi Morikawa
Yoshitaka Hosaka, Ph.D.
Kazunari Nakao
Masayoshi Takeda
Takeshi Mochida
Reiko Nakano

Consolidated Financial Highlights

Years ended March 31
  Millions of Yen
2020
(forecast)
2019 2018
Net sales 103,000 109,643 106,761
Operating income 7,700 10,590 11,662
Income before income taxes
and minority interests
11,642 12,116
Income taxes 3,207*1 3,092*2
Net income 5,800 8,435 9,023
Total assets 159,019 155,047
R&D expenditures 12,000 13,003 11,912
Capital expenditures 2,200 1,299 1,001
  Yen
Net income per share 147.9 212.9 227.3
Cash dividends per share 80.0 170.0 170.0
  • *1 As a result of tax effect accounting, corporate tax, resident tax and business tax (total ¥2,835 million), income taxes-deferred (-¥371 million) is included.
  • *2 As a result of tax effect accounting, corporate tax, resident tax and business tax (total ¥3,363 million), income taxes-deferred (-¥270 million) is included.

Sales of Main Products

Years ended March 31
  Billions of Yen
Products 2020
(forecast)
2019 2018
Tramcet® Analgesic for chronic pain and pain after tooth extraction 8.1 20.2 22.8
Lexapro® Antidepressant 16.1 15.0 13.7
Epadel Drug for hyperlipidemia and arteriosclerosis obliterans 13.3 14.5 18.3
Lialda® Treatment of ulcerative colitis 9.6 6.8 2.5
Atelec® Calcium channel blocker with a long-acting hypotensive effect 4.2 5.4 6.7
Doxil® Anticancer agent 2.9 2.7 0.6
Dinagest Therapeutic agent for endometriosis and adenomyosis 1.6 1.8 4.8
Treprost® Treatment for pulmonary arterial hypertension 1.6 1.7 1.7
Heparin Sodium for Inj. MOCHIDA Anticoagulant agent 1.5 1.5 1.6
Goofice® Treatment for chronic constipation 4.7 1.3
Arasena-A Antiviral drug 1.2 1.2 1.5
Florid® Antimycotic drug 0.9 1.0 1.0
Miraclid Drug for treatment of shock, and acute pancreatitis 1.0 1.0 1.1
Beselna Therapeutic agent for condyloma acuminatum and actinic keratosis 0.8 1.0 0.9
Movicol® Treatment for chronic constipation 3.3 0.3
Generic drugs 21.7 19.7 17.8
Skin Care Products 5.3 4.9 4.7